Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial (Journal of Neural Transmission, 2022)

(untitled) - Strube, W; Aksar, A; Bauer, I; Barbosa, S; Benros, M; Blankenstein, C; Campana, M; Davidovic, L; Glaichenhaus, N; Falkai, P; Görlitz, T; Hansbauer, M; et al.